138 related articles for article (PubMed ID: 30544064)
1. MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy.
Wang J; Zhao H; Yu J; Xu X; Liu W; Jing H; Li N; Tang Y; Li Y; Cai J; Jin J
Biomed Pharmacother; 2019 Feb; 110():646-655. PubMed ID: 30544064
[TBL] [Abstract][Full Text] [Related]
2. MiR-320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling.
Wang J; Zhao H; Yu J; Xu X; Jing H; Li N; Tang Y; Wang S; Li Y; Cai J; Jin J
Cancer Sci; 2021 Feb; 112(2):575-588. PubMed ID: 33251678
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
Zhuang LK; Yang YT; Ma X; Han B; Wang ZS; Zhao QY; Wu LQ; Qu ZQ
Cell Death Dis; 2016 Apr; 7(4):e2203. PubMed ID: 27100897
[TBL] [Abstract][Full Text] [Related]
4. Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-κB signaling pathway.
Shen ZT; Chen Y; Huang GC; Zhu XX; Wang R; Chen LB
BMC Cancer; 2019 Nov; 19(1):1075. PubMed ID: 31703572
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma.
Shao Y; Song X; Jiang W; Chen Y; Ning Z; Gu W; Jiang J
Mol Ther; 2019 Feb; 27(2):355-364. PubMed ID: 30503969
[TBL] [Abstract][Full Text] [Related]
6. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.
Fornari F; Gramantieri L; Ferracin M; Veronese A; Sabbioni S; Calin GA; Grazi GL; Giovannini C; Croce CM; Bolondi L; Negrini M
Oncogene; 2008 Sep; 27(43):5651-61. PubMed ID: 18521080
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of miR-149 and PARP-2 in hepatocellular carcinoma and their roles in chemo/radiotherapy.
Lin L; Zhang YD; Chen ZY; Chen Y; Ren CP
Tumour Biol; 2016 Sep; 37(9):12339-12346. PubMed ID: 27300349
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
9. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Wang K; Liang Q; Wei L; Zhang W; Zhu P
Tumour Biol; 2016 Mar; 37(3):3823-30. PubMed ID: 26474589
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma.
Deng B; Qu L; Li J; Fang J; Yang S; Cao Z; Mei Z; Sun X
Sci Rep; 2016 May; 6():26679. PubMed ID: 27230656
[TBL] [Abstract][Full Text] [Related]
15. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT.
Wang Y; Yang Z; Wang L; Sun L; Liu Z; Li Q; Yao B; Chen T; Wang C; Yang W; Liu Q; Han S
Biomed Pharmacother; 2019 Jan; 109():991-999. PubMed ID: 30551553
[TBL] [Abstract][Full Text] [Related]
16. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.
Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L
Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.
Yang Y; Li M; Chang S; Wang L; Song T; Gao L; Hu L; Li Z; Liu L; Yao J; Huang C
Mol Med Rep; 2014 Nov; 10(5):2643-8. PubMed ID: 25174704
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
19. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression.
Ye J; Yao Y; Song Q; Li S; Hu Z; Yu Y; Hu C; Da X; Li H; Chen Q; Wang QK
Sci Rep; 2016 Oct; 6():34034. PubMed ID: 27698442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
